TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBVIE Share Price

Certificat

DE000SH8P8N2

Delayed Deutsche Boerse AG 06:00:39 17/05/2024 pm IST
4.67 EUR -1.27% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBVIE
Current month-5.59%
1 month-5.02%
Date Price Change
17/24/17 4.67 -1.27%
16/24/16 4.73 -1.25%
15/24/15 4.79 -4.96%
14/24/14 5.04 -0.20%
13/24/13 5.05 -0.98%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 06:00 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ABBVIE INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SH8P8N
ISINDE000SH8P8N2
Date issued 12/04/2022
Strike 214.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.23
Lowest since issue 3.16
Spread 0.08
Spread %1.68%

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
164.4 USD
Average target price
181.6 USD
Spread / Average Target
+10.47%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW